Pharmaceutical Toxicology and Drug Safety
Pharmaceutical toxicology ensures the safety of drugs from discovery through post-marketing surveillance. This session explores adverse drug reactions, off-target effects, and toxicokinetics. Preclinical testing models and biomarkers for drug-induced injury are examined. Challenges in predicting human toxicity based on animal data are addressed. Regulatory safety thresholds and benefit-risk evaluations are discussed. The role of pharmacovigilance in real-world monitoring is highlighted. Continuous improvement in testing and data analytics enhances drug safety profiles.
Related Conference of Pharmaceutical Toxicology and Drug Safety
November 13-14, 2025
8th International Conference on Global Toxicology and Risk Assessment
Amsterdam, Netherlands
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
Pharmaceutical Toxicology and Drug Safety Conference Speakers
Recommended Sessions
- Alternative Testing Methods and 3Rs in Toxicology
- Carcinogenic Risk and Chemical-Induced Cancers
- Chemical Risk Assessment Frameworks
- Climate Change and Toxicological Risk
- Computational Toxicology and AI Applications
- Ecotoxicology and Aquatic System Contamination
- Endocrine Disrupting Chemicals and Public Health
- Environmental Toxicology and Ecosystem Impact
- Food Safety and Chemical Contaminants
- Forensic Toxicology and Chemical Poisoning
- Genetic Toxicology and DNA Damage Assessment
- Global Trends in Toxicology Research and Innovation
- Heavy Metals and Toxic Element Exposure
- Human Biomonitoring and Exposure Science
- Immunotoxicology and Hypersensitivity Reactions
- Industrial and Occupational Toxicology
- Nanotoxicology and Engineered Nanomaterials
- Neurotoxicology and Developmental Exposure
- Pesticide Toxicology and Risk Management
- Pharmaceutical Toxicology and Drug Safety
- Regulatory Toxicology and Global Policy Trends
- Risk Communication in Toxicology
- Toxicity of Consumer Products and Personal Care Items
- Toxicogenomics and Systems Toxicology
- Toxicokinetics and Chemical Fate in the Body
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Alternative Testing Methods and 3Rs in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Carcinogenic Risk and Chemical-Induced Cancers - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Chemical Risk Assessment Frameworks - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Climate Change and Toxicological Risk - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Computational Toxicology and AI Applications - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Ecotoxicology and Aquatic System Contamination - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Endocrine Disrupting Chemicals and Public Health - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Environmental Toxicology and Ecosystem Impact - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Food Safety and Chemical Contaminants - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Forensic Toxicology and Chemical Poisoning - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Genetic Toxicology and DNA Damage Assessment - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Global Trends in Toxicology Research and Innovation - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Heavy Metals and Toxic Element Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Human Biomonitoring and Exposure Science - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Immunotoxicology and Hypersensitivity Reactions - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Industrial and Occupational Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Nanotoxicology and Engineered Nanomaterials - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neurotoxicology and Developmental Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pesticide Toxicology and Risk Management - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmaceutical Toxicology and Drug Safety - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Regulatory Toxicology and Global Policy Trends - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Risk Communication in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicity of Consumer Products and Personal Care Items - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicogenomics and Systems Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicokinetics and Chemical Fate in the Body - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)